← Leaderboards
Todd A Fehniger
Washington University
$7,042,287
Attributed
$7,042,287
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $963.3K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,042,287 · 5
By mechanism
R01$3,935,629 · 2
P50$2,524,143 · 2
K08$582,515 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- John F Dipersio$33,235,840
- Michael Rettig$2,109,266
- Christopher Michael Sturgeon$5,222,741
- Celia Claire Cubitt$152,258
- Daniel C Link$19,842,999
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoNatural Killer CellsMediatingCellsImmuneCellular BiologyCytokineAllogenicLeukemiaFutureResponseExhibitsImmune SystemIn VitroAcute Myelocytic LeukemiaClinical TrialsMemoryDoseImmunotherapyLongevityRelapseDisease RemissionRefractoryResistance
Grant awards (22)
Project 2: Memory-like NK cell therapy for AML relapsed after allogeneic transplant$349,875
P50 · FY2025 · CA · contact PI
Project 2: Memory-like NK cell therapy for AML relapsed after allogeneic transplant$335,880
P50 · FY2024 · CA · contact PI
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.$238,817
P50 · FY2023 · CA · contact PI
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.$328,940
P50 · FY2022 · CA · contact PI
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.$276,241
P50 · FY2021 · CA · contact PI
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY$614,214
R01 · FY2020 · CA · contact PI
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.$326,161
P50 · FY2020 · CA · contact PI
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY$595,787
R01 · FY2019 · CA · contact PI
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.$319,127
P50 · FY2019 · CA · contact PI
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY$614,214
R01 · FY2018 · CA · contact PI
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.$342,469
P50 · FY2018 · CA · contact PI
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.$6,633
P50 · FY2018 · CA · contact PI
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY$614,214
R01 · FY2017 · CA · contact PI
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION$380,000
R01 · FY2016 · AI · contact PI
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION$380,000
R01 · FY2015 · AI · contact PI
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION$380,000
R01 · FY2014 · AI · contact PI
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION$357,200
R01 · FY2013 · AI · contact PI
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation$116,503
K08 · FY2013 · HL · contact PI
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation$116,503
K08 · FY2012 · HL · contact PI
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation$116,503
K08 · FY2011 · HL · contact PI
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation$116,503
K08 · FY2010 · HL · contact PI
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation$116,503
K08 · FY2009 · HL · contact PI